Thursday - March 28, 2024
University of Texas Health Science Center at San Antonio: Bladder Cancer Patients Respond Well to New Immunotherapy Tested at Mays Cancer Center
March 20, 2021
SAN ANTONIO, Texas, March 20 (TNSJou) -- The University of Texas Health Science Center at San Antonio issued the following news release:

In patients with high-grade cancer in the lining of the bladder, cancer often comes back within a year following standard treatment.

Although there are several approved treatments, none have significantly improved survival with few side effects. However, a new study evaluating a novel immunotherapy called nadofaragene firadenovec (NF) . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products